Current Clinical Pathology

Biotargets of Cancer in Current Clinical Practice

Editors: Bologna, Mauro (Ed.)

  • Provides the latest information on the validation status of each novel biomarker
  • Covers the present debate on potential clinical use of newly discovered biochemical markers and on patentability of genetic information
  • Chapter authors are experts on the particular cancer type
see more benefits

Buy this book

eBook $259.00
price for USA (gross)
  • ISBN 978-1-61779-615-9
  • Digitally watermarked, DRM-free
  • Included format: PDF, EPUB
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $329.00
price for USA
  • ISBN 978-1-61779-614-2
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Rent the ebook  
  • Rental duration: 1 or 6 month
  • low-cost access
  • online reader with highlighting and note-making option
  • can be used across all devices
About this book

Biotargets of Cancer in Current Clinical Practice presents an updated and reasoned review of the current status of knowledge concerning the major cancer types with a special focus on the current biomarkers, genes involved and the potential future targets of innovative therapies. The volume includes for each major cancer type, a comprehensive although concise discussion of epidemiology, affirmed and innovative biomarkers for diagnosis, and descriptions of the relevant genes for prognosis and (individualized) therapy through biotarget-specific new molecular treatments, with the latest information on the validation status of each novel biomarker. Individual chapters are dedicated to the major cancer types, plus a special chapter on metastasis. The present debate on patentability of genetic information applied to diagnostics and therapeutics of cancer is also discussed.

About the authors

Mauro Bologna, MD
University of L’Aquila, L’Aquila, Italy

Reviews

From the reviews:

“In this book on clinically significant biotargets in cancer research, every organ system is thoroughly represented with adequate overviews and precise details of the biotargets. … the book is intended specifically for clinicians in the field, including medical students, residents, pathologists, and oncologists. … This is a well-written book that attempts to provide a wide spectrum of current scientific information about the clinical management of oncologic patients based on molecular aspects. … this book achieves its objectives while remaining easy to read.” (Natalie Webster, Doody’s Review Service, October, 2012)


Table of contents (19 chapters)

  • Central Nervous System Tumors

    Aloisi, Paolo (et al.)

    Pages 1-18

  • Head and Neck Tumours

    Hunter, Keith D. (et al.)

    Pages 19-59

  • Thyroid Cancer

    Locati, Laura D. (et al.)

    Pages 61-91

  • Targeted Therapies for Non-small-Cell Lung Cancer

    Metro, Giulio (et al.)

    Pages 93-114

  • Non-Hodgkin’s Lymphomas

    Zappasodi, Roberta (et al.)

    Pages 115-157

Buy this book

eBook $259.00
price for USA (gross)
  • ISBN 978-1-61779-615-9
  • Digitally watermarked, DRM-free
  • Included format: PDF, EPUB
  • ebooks can be used on all reading devices
  • Immediate eBook download after purchase
Hardcover $329.00
price for USA
  • ISBN 978-1-61779-614-2
  • Free shipping for individuals worldwide
  • Usually dispatched within 3 to 5 business days.
Rent the ebook  
  • Rental duration: 1 or 6 month
  • low-cost access
  • online reader with highlighting and note-making option
  • can be used across all devices
Loading...

Recommended for you

Loading...

Bibliographic Information

Bibliographic Information
Book Title
Biotargets of Cancer in Current Clinical Practice
Editors
  • Mauro Bologna
Series Title
Current Clinical Pathology
Copyright
2012
Publisher
Humana Press
Copyright Holder
Springer Science+Business Media, LLC
eBook ISBN
978-1-61779-615-9
DOI
10.1007/978-1-61779-615-9
Hardcover ISBN
978-1-61779-614-2
Series ISSN
2197-781X
Edition Number
1
Number of Pages
XVI, 564
Topics